cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer

计划入组 600 人 · 首次发布于 2025 年 11 月 5 日

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

计划入组 55 人 · 首次发布于 2019 年 11 月 8 日

Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC

计划入组 500 人 · 首次发布于 2025 年 11 月 5 日

HMC-B17

Biomodal's 6-Base Sequencing Technology Achieves 95% Accuracy in Early-Stage Colorectal Cancer Detection

ClearNote Health's Avantect Pancreatic Cancer Test Achieves 82.6% Sensitivity in Early Detection

ClearNote Health Receives UK Regulatory Approval for Multi-Cancer Detection Tests